Canaimex Inc
About us | Drug Targets 1. Anti-tumor; 2. Anti-depressant; 3. Other CNS intermediates; 4. ATPase inhibitors Products 1. Galanthamine analogues; 2. L-Carnitine and peptides asymmetric synthesis; 3. Paclitaxel derivatives 99% of semi-synthesis of extracts and cell cultures; 4. Ergoloid derivatives of semi-synthesis of extracts and cell cultures 5. L-Penicillamine and peptoids asymmetric synthesis; 6. Solanesol, Omega-3 oil, DHA, EPA polyunsaturated acid(PUA), alcohols; 7. Citronellal, alpha-pinene, angelica absolute, sassafras oil etc plant perfume; 8.(-)-epigallocatechin gallate, EGCG, EC, ECG polyalcohol tea extract; |
---|---|
Industry Focus | Pharmaceutical Chemicals, Bio-technology Products |
Business Type | Manufacturer |
Products/Services | Contract synthesis |
Our Markets | Worldwide |
No. of Employees | 101 - 500 People |
Annual Sales Range(USD) | US$2.5 Million - US$5 Million |
Year Established | 1993 |
Legal Representative(CEO) | steve chang |
Certificates | GMP |